Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Expression of 11β-hydroxysteroid dehydrogenase type 2 is deregulated in colon carcinoma

M. Moravec, J. Svec, P. Ergang, V. Mandys, L. Reháková, Z. Zádorová, J. Hajer, M. Kment, J. Pácha,

. 2014 ; 29 (4) : 489-96.

Language English Country Spain

Document type Journal Article, Research Support, Non-U.S. Gov't

Although the effects of glucocorticoids on proliferation, differentiation and apoptosis are well known, and steroid hormones have been identified to play a role in pathogenesis and the development of various cancers, limited data are available regarding the relationship between the local metabolism of glucocorticoids and colorectal adenocarcinoma (CRC) formation. Glucocorticoid metabolism is determined by 11β-hydroxysteroid dehydrogenases type 1 and 2 (11HSD1, 11HSD2), which increase the local concentration of cortisol due to the reduction of cortisone, or decrease this concentration due to the oxidation of cortisol. The objective of this study was to evaluate the extent of 11HSD1 and 11HSD2 mRNA in pre-malignant colorectal polyps and in CRC. The specimens were retrieved from patients by endoscopic or surgical resection and the expression of 11HSD1 and 11HSD2 was measured by real-time PCR. The polyps were of the following histological types: hyperplastic polyps and adenomas with low- or high-grade dysplasia. The neoplastic tissue of CRC obtained during tumor surgery was also studied. It was found that 11HSD2 was not only downregulated in CRC but already in the early stages of neoplastic transformation (adenoma with low-grade dysplasia). In contrast, the level of 11HSD1 was significantly increased in CRC but not in pre-malignant polyps. The results demonstrate that the downregulation of 11HSD2 gene expression is a typical feature of the development of colorectal polypous lesions and their transformation into CRC.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc15008524
003      
CZ-PrNML
005      
20150325104642.0
007      
ta
008      
150306s2014 sp f 000 0|eng||
009      
AR
024    7_
$a 10.14670/hh-29.10.489 $2 doi
035    __
$a (PubMed)24189979
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sp
100    1_
$a Moravec, Martin $u Institute of Physiology, Academy of Sciences of the Czech Republic, and Second Department of Internal Medicine, Third Faculty of Medicine, Prague, Czech Republic.
245    10
$a Expression of 11β-hydroxysteroid dehydrogenase type 2 is deregulated in colon carcinoma / $c M. Moravec, J. Svec, P. Ergang, V. Mandys, L. Reháková, Z. Zádorová, J. Hajer, M. Kment, J. Pácha,
520    9_
$a Although the effects of glucocorticoids on proliferation, differentiation and apoptosis are well known, and steroid hormones have been identified to play a role in pathogenesis and the development of various cancers, limited data are available regarding the relationship between the local metabolism of glucocorticoids and colorectal adenocarcinoma (CRC) formation. Glucocorticoid metabolism is determined by 11β-hydroxysteroid dehydrogenases type 1 and 2 (11HSD1, 11HSD2), which increase the local concentration of cortisol due to the reduction of cortisone, or decrease this concentration due to the oxidation of cortisol. The objective of this study was to evaluate the extent of 11HSD1 and 11HSD2 mRNA in pre-malignant colorectal polyps and in CRC. The specimens were retrieved from patients by endoscopic or surgical resection and the expression of 11HSD1 and 11HSD2 was measured by real-time PCR. The polyps were of the following histological types: hyperplastic polyps and adenomas with low- or high-grade dysplasia. The neoplastic tissue of CRC obtained during tumor surgery was also studied. It was found that 11HSD2 was not only downregulated in CRC but already in the early stages of neoplastic transformation (adenoma with low-grade dysplasia). In contrast, the level of 11HSD1 was significantly increased in CRC but not in pre-malignant polyps. The results demonstrate that the downregulation of 11HSD2 gene expression is a typical feature of the development of colorectal polypous lesions and their transformation into CRC.
650    _2
$a 11-beta-hydroxysteroiddehydrogenasa typ 1 $x analýza $x biosyntéza $7 D043205
650    _2
$a 11-beta-hydroxysteroiddehydrogenasa typ 2 $x analýza $x biosyntéza $7 D043209
650    _2
$a adenokarcinom $x enzymologie $7 D000230
650    _2
$a adenomové polypy $x enzymologie $7 D018256
650    _2
$a mladiství $7 D000293
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a senioři nad 80 let $7 D000369
650    _2
$a dítě $7 D002648
650    _2
$a kolorektální nádory $x enzymologie $7 D015179
650    _2
$a down regulace $7 D015536
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a laserová záchytná mikrodisekce $7 D061346
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prekancerózy $x enzymologie $7 D011230
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    _2
$a transkriptom $7 D059467
650    _2
$a nádorové biomarkery $x analýza $7 D014408
650    _2
$a mladý dospělý $7 D055815
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Svec, Jirí $u Institute of Physiology, Academy of Sciences of the Czech Republic, and Second Department of Internal Medicine, Third Faculty of Medicine, Prague, Czech Republic.
700    1_
$a Ergang, Peter $u Institute of Physiology, Academy of Sciences of the Czech Republic, Prague, Czech Republic.
700    1_
$a Mandys, Václav $u Department of Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Reháková, Lenka $u Department of Pathology, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Zádorová, Zdena $u Second Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Hajer, Jan $u Second Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Kment, Milan $u Second Department of Internal Medicine, Third Faculty of Medicine, Charles University, Prague, Czech Republic.
700    1_
$a Pácha, Jirí $u Institute of Physiology, Academy of Sciences of the Czech Republic, and Department of Physiology, Faculty of Science, Charles University, Prague, Czech Republic. pacha@biomed.cas.cz.
773    0_
$w MED00005439 $t Histology and histopathology $x 1699-5848 $g Roč. 29, č. 4 (2014), s. 489-96
856    41
$u https://pubmed.ncbi.nlm.nih.gov/24189979 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20150306 $b ABA008
991    __
$a 20150325104931 $b ABA008
999    __
$a ok $b bmc $g 1065797 $s 891324
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2014 $b 29 $c 4 $d 489-96 $i 1699-5848 $m Histology and histopathology $n Histol Histopathol $x MED00005439
LZP    __
$a Pubmed-20150306

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...